Market capitalisation is the post-issue share count in the offer document’s capital structure (12,29,18,109 shares) multiplied by the upper end of the price band, ₹45. It is arithmetic on those two filed figures, not a valuation.
| ₹ crore | 2023 | 2024 | 2025 | Dec 2025 |
|---|---|---|---|---|
| Revenue | ₹281.65 | ₹304.62 | ₹331.29 | ₹275.57 |
| Expenses | ₹267.02 | ₹285.48 | ₹296.78 | ₹239.83 |
| Net profit (PAT) | ₹5.82 | ₹12.21 | ₹24.38 | ₹27.03 |
| PAT margin | 2.1% | 4.0% | 7.4% | 9.8% |
| Total assets | ₹288.9 | ₹250.54 | ₹261.36 | ₹327.6 |
The founding owners and their group entities.
Post-issue pattern as filed with the NSE. Pre-issue register from the RHP capital structure, cross-checked against exchange data. Pre-issue percentages are taken from the disclosure, never estimated.
| Application | Shares | Amount at ₹45 |
|---|---|---|
| Retail (min)1 lot | 333 | ₹14,985 |
| Retail (max)13 lots | 4,329 | ₹1,94,805 |
| sHNI (min)14 lots | 4,662 | ₹2,09,790 |
| bHNI (min)67 lots | 22,311 | ₹10,03,995 |
One lot is 333 shares, so a single application at the ₹45 cut-off costs ₹14,985. Retail applications are capped at ₹2,00,000, which is 13 lots for this issue. Amounts are shown at the upper band because applications are made at the cut-off price.
Strengths and risk factors from this issue’s prospectus aren’t available yet.
Exchange bidding runs 10:00 am – 5:00 pm IST on each day of the issue; UPI mandates must be accepted by 5:00 pm on the closing day, and brokers may stop taking bids earlier. Allotment, refund and credit dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them.
Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Hexagon Nutrition Limited, the registrar is Kfin Technologies Ltd. — allotment is finalised in the days between the issue closing on 09 Jun 2026 and listing on 12 Jun 2026.
The registrar publishes allotment on its own portal: KFintech. Your bank will also show the blocked amount released if shares were not allotted.
Bidding for the Hexagon Nutrition Limited IPO opens on 5 June 2026 and closes on 9 June 2026. Exchange bidding runs from 10:00 am to 5:00 pm IST on each day; UPI mandates must be accepted by 5:00 pm on the closing day, and brokers may stop taking bids somewhat earlier.
The shares are scheduled to list on 12 June 2026 on NSE. Trading starts at 10:00 am IST after the special pre-open session that discovers the listing price.
Applications are made through a broker's app or a bank's net banking using ASBA, or by UPI mandate, between 5 June 2026 and 9 June 2026. The amount is only blocked, not debited, until allotment. Retail bids of up to ₹2,00,000 are usually placed at the cut-off price (₹45); a UPI mandate must be approved by 5:00 pm on the closing day.
9 June 2026 is the last day of bidding. Allotment is then expected on 10 June 2026, refunds and demat credit on 11 June 2026, and listing on 12 June 2026 — tentative until confirmed.
The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.
Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹40 on a ₹45 upper band means the grey market is dealing at issue price plus that premium.
The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.